bioAffinity Technologies Inc (NASDAQ: BIAF) shares trade higher in Wednesday’s premarket after announcing a live virtual roundtable for its CyPath Lung test.
Importance Rank:
1
bioAffinity Technologies Inc (NASDAQ: BIAF) shares trade higher in Wednesday’s premarket after announcing a live virtual roundtable for its CyPath Lung test.
The UCW Newswire : Financial, Business and Tech NewsCopyright © Louis Velazquez. All Rights Reserved.